Coppell Advisory Solutions LLC Astrazeneca PLC Transaction History
Coppell Advisory Solutions LLC
- $680 Billion
- Q3 2024
A detailed history of Coppell Advisory Solutions LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 18,891 shares of AZN stock, worth $1.25 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
18,891
Previous 18,702
1.01%
Holding current value
$1.25 Million
Previous $1.46 Billion
0.53%
% of portfolio
0.22%
Previous 0.24%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...